new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Merck Sharp x26 Dohme Corp
Merck Sharp x26 Dohme Corporation
Merck Sharp x26 Dohme Corp A Corporation A Subsidiary Of Merck x26 Co Inc
Merck Sharp x26 Dohme Corp And Northwestern University
Merck Sharp x26 Dohme Corp_20131212
Merck Sharp x26 Dohme Corp Institute De Recherche Pierre Fabre
  

Merck Sharp & Dohme Corp patents

Bulk PDF Downloads
Recent patent applications related to Merck Sharp & Dohme Corp. Merck Sharp & Dohme Corp is listed as an Agent/Assignee. Note: Merck Sharp & Dohme Corp may have other listings under different names/spellings. We're not affiliated with Merck Sharp & Dohme Corp, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Merck Sharp & Dohme Corp-related inventors




Date Merck Sharp & Dohme Corp patents (updated weekly) - BOOKMARK this page
07/07/16Mono- and di-peg il-10 production; and uses
03/26/15Mono- and di-peg il-10 production; and uses
01/08/15Dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
10/04/12Novel cationic lipids with short lipid chains for oligonucleotide delivery
08/09/12Combination therapy using a beta 3 adrenergic receptor agonists and an antimuscarinic agent
12/01/16 new patent  Factor xia inhibitors
12/01/16 new patent  Novel disintegration systems for pharmaceutical dosage forms
12/01/16 new patent  Tablet formulation for cgrp active compounds
12/01/16 new patent  Fixed-dose combinations of antiviral compounds
12/01/16 new patent  Factor xia inhibitors
11/24/16Pharmaceutical composition of selective hcv ns3/4a inhibitors
11/24/16Factor xia inhibitors
11/24/16Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
11/17/16Antidiabetic compounds
11/17/16Metallo-beta-lactamase inhibitors
11/10/16Inhibitors of the renal outer medullary potassium channel
11/10/16C-6 spirocarbocyclic iminothiadiazine dioxides as bace inhibitors, compositions, and their use
11/10/16Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
11/10/16Btk inhibitors
11/03/16Media milling process for the manufacture of active pharmaceutical ingredients in propellants
11/03/16Liposomal formulations for allosteric akt inhibitors
11/03/16Spirocyclic hetercycle compounds useful as hiv integrase inhibitors
11/03/16Thioether-piperidinyl orexin receptor antagonists
11/03/162-amino-3-ester-pyridyl orexin receptor antagonists
11/03/16Diazepane orexin receptor antagonists
11/03/16Piperidinyloxy lactone orexin receptor antagonists
11/03/16Fused bicyclic isoxazolines as inhibitors of cholesterol ester transfer protein
10/27/16Hiv protease inhibitors
10/27/16Carbamate benzoxazine propionic acids and acid derivatives for modulation of rorgamma activity and the treatment of disease
10/27/16Novel tricyclic calcium sensing receptor antogonists for the treatment of osteopososis
10/27/16Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
10/27/16Erk inhibitors
10/27/16Btk inhibitors
10/27/16Gene signature biomarkers of tumor response to pd-1 antagonists
10/27/16Pd-l1 gene signature biomarkers of tumor response to pd-1 antagonists
10/20/16Treating cancer with a combination of a pd-1 antagonist and a vegfr inhibitor
10/20/16Glucose-responsive insulin conjugates
10/20/16Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of rorgamma activity and the treatment of disease
10/20/16Indoline compounds as aldosterone synthase inhibitors
10/20/162-pyridyloxy-3-ester-4-ether orexin receptor antagonists
10/20/162-acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of rorgamma activity and the treatment of disease
10/20/16Inhibitors of the renal outer medullary potassim channel
10/20/16Soluble guanylate cyclase activators
10/20/16Soluble guanylate cyclase activators
10/20/16Ifn-gamma gene signature biomarkers of tumor response to pd-1 antagonists
10/20/16Immunohistochemical proximity assay for pd-1 positive cells and pd-ligand positive cells in tumor tissue
10/13/16Hiv protease inhibitors
10/13/16Piperidine or piperazine linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
10/13/16Process for making reverse transcriptase inhibitors
10/13/16Aryl linked imidazole and triazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
10/13/16Method for preparing crystalline insulin
10/06/16Composition of a non-nucleoside reverse transcriptase inhibitor
10/06/16Compounds inhibiting leucine-rich repeat kinase enzyme activity
10/06/16N-glycosylated insulin analogues
09/29/16Ceftolozane antibiotic compositions
09/29/16Antidiabetic bicyclic compounds
09/29/16Cycloalkyl nitrile pyrazolo pyridones as janus kinase inhibitors
09/29/16Novel antibacterial agents
09/22/16Geminally substituted cyanoethylpyrazolo pyridones as janus kinase inhibitors
09/22/16N-(2-cyano heterocyclyl) pyrazolo pyridones as janus kinase inhibitors
09/22/16Acyclic cyanoethylpyrazolo pyridones as janus kinase inhibitors
09/15/16C6-spiro iminothiadiazine dioxides as bace inhibitors, compositions, and their use
09/08/16Antidiabetic tricyclic compounds
09/08/16Factor xia inhibitors
09/08/16Inhibitors of the renal outer medullary potassium channel
Patent Packs
09/08/16Thiophene-substituted tetracyclic compounds and methods ofuse thereof for the treatment of viral diseases
09/08/16Process for preparing tetracyclic heterocycle compounds
09/01/16Glucose-responsive insulin conjugates
09/01/16Thermostable respiratory synctial virus (rsv) vaccine compositions
09/01/16Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use
09/01/16Thermostable respiratory synctial virus (rsv) vaccine compositions
09/01/16Methods and intermediates for preparing macrolactams
09/01/16Glucose-responsive insulin conjugates
09/01/16Method of microwave vacuum drying spherical-shaped pellets of biological materials
09/01/16Complimentary trade drug delivery system
08/25/16Polycyclic heterocycle derivatives and methods of use thereof for the treatment of viral diseases
08/25/16Cathepsin cysteine protease inhibitors
08/18/16Novel pyrrolidine derived beta 3 adrenergic receptor agonists
08/11/16Trka kinase inhibitors, compositions and methods thereof
08/11/16Substituted quinolizine derivatives useful as hiv integrase inhibitors
Patent Packs
08/11/16Solid forms of ceftolozane
08/11/16Method of obtaining thermostable dried vaccine formulations
08/11/16Trka kinase inhibitors, compositions and methods thereof
08/11/16Aryl methyl benzoquinazolinone m1 receptor positive allosteric modulators
08/11/16Factor xia inhibitors
08/11/16Trka kinase inhibitors, compositions and methods thereof
08/04/16Formulations for cgrp receptor antagonists
08/04/16Tricyclic gyrase inhibitors
08/04/16C5-spiro iminothiazine dioxides as bace inhibitors, compositions, and their use
07/28/162-pyridyloxy-4-ester orexin receptor antagonists
07/28/162,2-difluorodioxolo a2a receptor antagonists
07/28/16Fc containing polypeptides having increased binding to fcgammariib
07/21/16Antidiabetic tricyclic compounds
07/21/16Inhibitors of the renal outer medullary potassium channel
07/21/16Purine inhibitors of human phosphatidylinositol 3-kinase delta
07/14/16Modulation of tumor immunity
07/14/16Preparation and use of 3-pyridyl substituted- 6,6-difluoro bicyclic himbacine derivatives as par-1 receptor antagonists
07/14/16Preparation and use of 7a-heterocycle substituted- 6,6-difluoro bicyclic himbacine derivatives as par-1 receptor antagonists
07/14/16Compounds inhibiting leucine-rich repeat kinase enzyme activity
07/07/16Ceftolozane-tazobactam pharmaceutical compositions
07/07/16Immediate-release tablet formulations of a thrombin receptor antagonist
07/07/16Methods of immunization with varicella zoster virus antigen
07/07/16Treating cancer with a combination of a pd-1 antagonist and dinaciclib
07/07/16Piperazine-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
07/07/16Methods and compositions for co-expression of polypeptides of inerest and il6
07/07/16Expression vectors for recombinant protein production in mammalian cells
06/30/16Preparation and use of 7a-amide substituted- 6,6-difluoro bicyclic himbacine derivatives as par-1 receptor antagonists
06/30/16Thiazole orexin receptor antagonists
06/23/16Oxazole orexin receptor antagonists
06/23/16Process for making beta 3 agonists and intermediates
Social Network Patent Pack
06/23/167-aminocephem derivative compounds
06/23/16Forms of r)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
06/16/16Formulations for cathepsin k inhibitors with vitamin d
06/16/16Oral pharmaceutical formulation of omarigliptin
06/16/16Substituted amidopyrazole inhibitors of interleukin receptor-associated kinases (irak-4)
06/16/16Pegylated interleukin-10
06/09/16Quinoline carboxamide and quinoline carbonitrile derivatives as mglur2-negative allosteric modulators, compositions, and their use
06/09/16Quinoline carboxamide and quinoline carbonitrile derivatives as mglur2-negative allosteric modulators, compositions, and their use
06/09/16Quinoline carboxamide and quinoline carbonitrile derivatives as mglur2-negative allosteric modulators, compositions, and their use
06/09/16Quinoline carboxamide and quinoline carbonitrile derivatives as mglur2-negative allosteric modulators, compositions, and their use
Patent Packs
06/09/16Piperazine derivatives as hiv protease inhibitors
06/09/16Co-crystal of the par-1 receptor antagonists vorapaxar and asprin
06/02/16Dengue virus vaccine compositions and methods of use thereof
05/26/16Heterocyclic compounds and methods of use thereof for the treatment of hepatitis c
05/26/16Non-nucleoside reverse transcriptase inhibitors
05/26/16Triazolo-pyrazinyl derivatives useful as soluble guanylate cyclase activators
05/19/16Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
05/19/16Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
05/12/16Substituted benzofuran compounds and methods of use thereof for the treatment of viral diseases
05/12/16Process for making cgrp receptor antagonists
05/12/16Cmv neutralizing antigen binding proteins
05/12/16Methods of measuring gene expression in facs-sorted cells
05/12/16Compositions and methods for treating cancer
05/05/16Process for the preparation of chiral tert-butyl 4-((1r,2s,5r)-6-(benzyloxy)-7-oxo-1,6-diazabicyclo[3.2.1]octane-2-carboxamido)piperidine-1-carboxylate derivatives and (2s,5r)-7-oxo-n-piperidin-4-yl-6-(sulfoxy)-1,6-diazabicyclo[3.2.1]octane-2-carboxamide
05/05/16Cyclic phosphonate substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
04/28/16Treating infections with ceftolozane/tazobactam in subjects having impaired renal function
04/28/16Co-agonists of the glucagon and glp-1 receptors
04/21/16Combination therapies for cancer
04/21/16Imidazole derivatives and methods of use thereof for improving the pharmacokinetics of a drug
04/21/16Fused tricyclic heterocyclic compounds as hiv integrase inhibitors
04/14/162-hydroxymethyl-substituted orexin receptor antagonists
04/07/16Selective glycosidase inhibitors and uses thereof
03/24/16Process of making and using pharmaceutical formulations of antineoplastic agents
03/24/16Method for preparing antibodies having improved properties
03/24/16Immunohistochemical assay for detecting expression of programmed death ligand 1 (pd-l1) in tumor tissue
03/24/16Assay for determining endogenous levels of analyte in vivo
03/17/16Recombinant subunit dengue virus vaccine
03/17/16Amidation process
03/17/16Crystalline polymorphic forms of an antidiabetic compound
03/17/16Quinoline amide m1 receptor positive allosteric modulators
Patent Packs
03/17/16Alpha 7 nicotinic acetylcholine receptor modulators and uses thereof-iii
03/17/16Cetp inhibitors
03/10/16Hydroxy-substituted orexin receptor antagonists
03/10/16Halo and trifluoromethyl substituted orexin receptor antagonists
03/10/16Novel compounds that are erk inhibitors
03/10/16Fdf03 antibodies and uses thereof
03/03/16Thiazole-substituted aminoheteroaryls as spleen tyrosine kinase inhibitors
03/03/16Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
03/03/164-pyridone derivative compounds and uses thereof as hiv integrase inhibitors
02/25/16Immobilized ketoreductases and process for making and using immobilized ketoreductase
02/18/162'-disubstituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
02/18/16Factor xia inhibitors
02/11/16Triazolopyridyl compounds as aldosterone synthase inhibitors
02/11/16Adapted lepidopteran insect cells for the production of recombinant proteins
02/11/16Biocatalytic transamination process
02/11/16Methods and compositions for treating cancer
02/11/16C6-azaspiro iminothiadiazine dioxides as bace inhibitors, compositions, and their use
02/04/16Imidazopyridyl compounds as aldosterone synthase inhibitors
01/28/16Inhibitors of the renal outer medullary potassium channel
01/28/16Process for preparing chiral dipeptidyl peptidase-iv inhibitors
Social Network Patent Pack
01/21/16S-imino-s-oxo-iminothiazine compounds as bace inhibitors, compositions, and their use
01/21/16S-imino-s-oxo-iminothiadiazine compounds as bace inhibitors, compositions, and their use
01/21/162-pyridyloxy-4-ether orexin receptor antagonists
01/21/16Substituted pyridizinone derivatives as pde10 inhibitors
01/21/16C2-azaspiro iminothiazine dioxides as bace inhibitors, compositions, and their use
01/21/16Cell line 3m
01/14/16Compositions and methods for treating cancer
01/14/16Compounds inhibiting leucine-rich repeat kinase enzyme activity
01/14/16Compounds inhibiting leucine-rich repeat kinase enzyme activity
01/14/16Compounds inhibiting leucine-rich repeat kinase enzyme activity
01/14/16Compounds inhibiting leucine-rich repeat kinase enzyme activity
01/07/16Gastro-retentive formulations
01/07/16Ceftolozane antibiotic compositions
01/07/16Novel indole derivatives useful as anti-diabetic agents
01/07/16Antidiabetic bicyclic compounds
01/07/16Inhibitors of the renal outer medullary potassium channel
12/31/15O-glycosylated carboxy terminal portion (ctp) peptide-based insulin and insulin analogues
12/31/15Methods for increasing n-glycan occupancy and reducing production of hybrid n-glycans in pichia pastoris strains lacking alg3 expression
12/24/15Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
12/24/152,6,7 substituted purines as hdm2 inhibitors
Social Network Patent Pack
12/24/15Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
12/24/15Factor ixa inhibitors
12/24/15Mdl-1 ligand
12/24/15Immobilized transaminases and process for making and using immobilized transaminase
12/17/15Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/17/15Heterobicyclo-substituted [1,2,4]triazolo[1,5-c]quinazolin-5-amine compounds with a2a antagonist properties
12/17/15Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
12/10/15Substituted isoquinolines as crth2 receptor modulators
12/10/15Iminothiadiazine dioxides containing a thioamide, amidine, or amide oxime group as bace inhibitors, compositions, and their use
12/10/15Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
12/10/15Purine inhibitors of human phosphatidylinositol 3-kinase delta
12/10/152,6,7,8 substituted purines as hdm2 inhibitors
12/10/15Btk inhibitors
12/10/15Btk inhibitors
12/10/15Antibodies that bind to human programmed death ligand 1 (pd-l1)
12/03/15Spirocyclic cetp inhibitors
12/03/15Dual chamber mixing syringes and methods of using same
12/03/15Medication injector with near-empty alert
12/03/15Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment of diabetes
12/03/15C2,c6 oxacyclic-fused thiazine dioxide compounds as bace inhibitors, compositions, and their use
11/26/15Heterocycle-substituted tetracyclic compounds and methods of use thereof for the treatment of viral diseases
11/26/15Novel 2-pyridinecarboxamide derivatives, compositions containing such compounds, and methods of treatment
11/26/15Isotopically labeled biaryl urea compounds
11/26/15Novel glucokinase activator compounds, compositions containing such compounds, and methods of treatment
11/26/15Novel antibacterial agents for the treatment of gram positive infections
11/26/15Pmt2-, och1-, pmt5- mutant cells
11/19/15Process for making reverse transcriptase inhibitors
11/19/15Amino-pyrimidine-containing spleen tyrosine kinase (syk) inhibitors
11/19/154-pyridinonetriazine derivatives as hiv integrase inhibitors
11/19/15Substituted pyrrolopyrimidines as hdm2 inhibitors
Social Network Patent Pack
11/19/15Inhibitors of the renal outer medullary potassium channel
11/19/15Factor ixa inhibitors
11/19/15Process for purifying insulin and analogues thereof
11/19/15Liquid formulations for an anti-tnf alpha antibody
11/19/15Solution formulations of engineered anti-il-23p19 antibodies
11/12/15Methods of treating diabetes by administering a glucagon receptor antagonist in combination with a cholesterol absorption inhibitor
11/12/15Indazole compounds as aldosterone synthase inhibitors
11/12/15Method for treating a disease associated with soluble, oligomeric species of amyloid beta 1-42
11/12/152-pyridylamino-4-nitrile-piperidinyl orexin receptor antagonists
11/12/153-ester-4 substituted orexin receptor antagonists
11/12/152-pyridyloxy-4-nitrile-4-substituted orexin receptor antagonists
11/12/15Factor ixa inhibitors
11/12/154-fluoropiperidine orexin receptor antagonists
11/12/15Biomarkers for psoriasis treatment response
11/05/15Nucleoside kinase bypass compositions and methods
11/05/15Syn3 compositions and methods
11/05/15Thrombin inhibitors
11/05/15Nucleoside kinase bypass compositions and methods
11/05/15Disulfide masked prodrug compositions and methods
10/29/15Aldosterone synthase inhibitors
10/29/15Therapeutic thiazolidinone compounds
10/29/15Iminothiadiazine dioxide compounds as bace inhibitors, compositions and their use
10/29/15Cyclobutyl benzimidazoles as pde 10 inhibitors
10/29/15Cyclopropyl imidazopyridine pde10 inhibitors
10/29/15Pyrimidine pde10 inhibitors
10/29/15Spirocyclic sulfones as gamma secretase inhibitors
10/29/15Oxyntomodulin analogs
10/29/15On-column refolding and purifying of lipoproteins
10/29/15Lyophilized spherical pellets of anti-il-23 antibodies







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Merck Sharp & Dohme Corp in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Merck Sharp & Dohme Corp with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';